Pleiotrophin Signaling through Anaplastic Lymphoma Kinase Is Rate-limiting for Glioblastoma Growth

This publication has 26 references indexed in Scilit:

• Identification of Anaplastic Lymphoma Kinase as a Receptor for the Growth Factor Pleiotrophin
  Journal of Biological Chemistry, 2001
• PTEN: a tumour suppressor that functions as a phospholipid phosphatase
  Trends in Cell Biology, 1999
• Genetic instability leads to loss of both p53 alleles in a human glioblastoma
  Oncogene, 1998
• Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
  Proceedings of the National Academy of Sciences, 1997
• Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system
  Oncogene, 1997
• Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin
  Proceedings of the National Academy of Sciences, 1996
• Molecular genetics and molecular biology advances in brain tumors
  Current Opinion in Oncology, 1996
• A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
  Proceedings of the National Academy of Sciences, 1994
• Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
  Science, 1994
• Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
  Nature, 1992